← Browse by Condition
Medical Condition

anaplastic lymphoma kinase

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1
NCT07001384 Phase 1
Recruiting

A Study of Alectinib and Duvelisib in People With Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma (ALK+ALCL)

Enrollment
30 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance...
View Trial →